201 related articles for article (PubMed ID: 37317053)
1. Splicing factor TRA2A contributes to esophageal cancer progression via a noncanonical role in lncRNA m
Bei M; Hao S; Lin K; Chen Q; Cai Y; Zhao X; Jiang L; Lin L; Dong G; Xu J
Cancer Sci; 2023 Aug; 114(8):3216-3229. PubMed ID: 37317053
[TBL] [Abstract][Full Text] [Related]
2. TRA2A Binds With LncRNA MALAT1 To Promote Esophageal Cancer Progression By Regulating EZH2/β-catenin Pathway.
Zhao X; Chen Q; Cai Y; Chen D; Bei M; Dong H; Xu J
J Cancer; 2021; 12(16):4883-4890. PubMed ID: 34234858
[TBL] [Abstract][Full Text] [Related]
3. m
Jin D; Guo J; Wu Y; Du J; Yang L; Wang X; Di W; Hu B; An J; Kong L; Pan L; Su G
J Hematol Oncol; 2019 Dec; 12(1):135. PubMed ID: 31818312
[TBL] [Abstract][Full Text] [Related]
4. Methyltransferase-like 3 facilitates the stem cell properties of esophageal cancer by upregulating patched homolog 1 via N6-methyladenosine methylation.
Liang H; Fang C; Zhang L
Am J Physiol Cell Physiol; 2023 Sep; 325(3):C770-C779. PubMed ID: 37575058
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA MALAT1 potentiates growth and inhibits senescence by antagonizing ABI3BP in gallbladder cancer cells.
Lin N; Yao Z; Xu M; Chen J; Lu Y; Yuan L; Zhou S; Zou X; Xu R
J Exp Clin Cancer Res; 2019 Jun; 38(1):244. PubMed ID: 31174563
[TBL] [Abstract][Full Text] [Related]
6. [Roles and mechanisms of m
Yan BR; Wang P; Li YS; Yang LK; Li QY; Kan X; Wang JT; Sun YN
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Dec; 57(12):1470-1478. PubMed ID: 36707952
[No Abstract] [Full Text] [Related]
7. METTL3-Mediated m
Mao Y; Li W; Weng Y; Hua B; Gu X; Lu C; Xu B; Xu H; Wang Z
Cell Transplant; 2022; 31():9636897221122997. PubMed ID: 36073002
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of METTL14 and m6A modification of lncRNA MALAT1 in the proliferation of oral squamous cell carcinoma cells.
Li J; Momen-Heravi F; Wu X; He K
Oral Dis; 2023 Jul; 29(5):2012-2026. PubMed ID: 35467063
[TBL] [Abstract][Full Text] [Related]
9. Effect of m6A methyltransferase METTL3 -mediated MALAT1/E2F1/AGR2 axis on adriamycin resistance in breast cancer.
Li S; Jiang F; Chen F; Deng Y; Pan X
J Biochem Mol Toxicol; 2022 Jan; 36(1):e22922. PubMed ID: 34964205
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of long noncoding RNA MALAT1 contributes to proliferation and metastasis in esophageal squamous cell carcinoma.
Hu L; Wu Y; Tan D; Meng H; Wang K; Bai Y; Yang K
J Exp Clin Cancer Res; 2015 Jan; 34(1):7. PubMed ID: 25613496
[TBL] [Abstract][Full Text] [Related]
11. Silencing of long noncoding RNA MALAT1 by miR-101 and miR-217 inhibits proliferation, migration, and invasion of esophageal squamous cell carcinoma cells.
Wang X; Li M; Wang Z; Han S; Tang X; Ge Y; Zhou L; Zhou C; Yuan Q; Yang M
J Biol Chem; 2015 Feb; 290(7):3925-35. PubMed ID: 25538231
[TBL] [Abstract][Full Text] [Related]
12. METTL3-stabilized lncRNA SNHG7 accelerates glycolysis in prostate cancer via SRSF1/c-Myc axis.
Liu J; Yuan JF; Wang YZ
Exp Cell Res; 2022 Jul; 416(1):113149. PubMed ID: 35405116
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA LINC01234 silencing exerts an anti-oncogenic effect in esophageal cancer cells through microRNA-193a-5p-mediated CCNE1 downregulation.
Ma J; Han LN; Song JR; Bai XM; Wang JZ; Meng LF; Li J; Zhou W; Feng Y; Feng WR; Ma JJ; Hao JT; Shen ZQ
Cell Oncol (Dordr); 2020 Jun; 43(3):377-394. PubMed ID: 32130660
[TBL] [Abstract][Full Text] [Related]
14. METTL3 enhances the stability of MALAT1 with the assistance of HuR via m6A modification and activates NF-κB to promote the malignant progression of IDH-wildtype glioma.
Chang YZ; Chai RC; Pang B; Chang X; An SY; Zhang KN; Jiang T; Wang YZ
Cancer Lett; 2021 Jul; 511():36-46. PubMed ID: 33933553
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA DGCR5 involves in tumorigenesis of esophageal squamous cell carcinoma via SRSF1-mediated alternative splicing of Mcl-1.
Duan Y; Jia Y; Wang J; Liu T; Cheng Z; Sang M; Lv W; Qin J; Liu L
Cell Death Dis; 2021 Jun; 12(6):587. PubMed ID: 34099633
[TBL] [Abstract][Full Text] [Related]
16. LncRNA HOTAIR-mediated MTHFR methylation inhibits 5-fluorouracil sensitivity in esophageal cancer cells.
Zhang S; Zheng F; Zhang L; Huang Z; Huang X; Pan Z; Chen S; Xu C; Jiang Y; Gu S; Zhao C; Zhang Q; Shi G
J Exp Clin Cancer Res; 2020 Jul; 39(1):131. PubMed ID: 32653028
[TBL] [Abstract][Full Text] [Related]
17. TRA2A Promoted Paclitaxel Resistance and Tumor Progression in Triple-Negative Breast Cancers via Regulating Alternative Splicing.
Liu T; Sun H; Zhu D; Dong X; Liu F; Liang X; Chen C; Shao B; Wang M; Wang Y; Sun B
Mol Cancer Ther; 2017 Jul; 16(7):1377-1388. PubMed ID: 28416606
[TBL] [Abstract][Full Text] [Related]
18. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
[TBL] [Abstract][Full Text] [Related]
19. KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3.
Lan T; Li H; Zhang D; Xu L; Liu H; Hao X; Yan X; Liao H; Chen X; Xie K; Li J; Liao M; Huang J; Yuan K; Zeng Y; Wu H
Mol Cancer; 2019 Dec; 18(1):186. PubMed ID: 31856849
[TBL] [Abstract][Full Text] [Related]
20. Caprin-1 plays a role in cell proliferation and Warburg metabolism of esophageal carcinoma by regulating METTL3 and WTAP.
Gao Y; Yuan L; Ke C; Pei Z; Liu X; Wu R; Kui X; Zhang Y
J Transl Med; 2023 Feb; 21(1):159. PubMed ID: 36855123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]